Gossamer Bio (FRA:4GB) Total Stockholders Equity : €24.58 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Gossamer Bio Total Stockholders Equity?

Gossamer Bio's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €24.58 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Gossamer Bio's Book Value per Share for the quarter that ended in Mar. 2024 was €0.11. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Gossamer Bio's Debt-to-Equity for the quarter that ended in Mar. 2024 was 7.82.

Gossamer Bio Total Stockholders Equity Historical Data

The historical data trend for Gossamer Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Total Stockholders Equity Chart

Gossamer Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

317.24

263.60

107.50

11.40

57.56

Gossamer Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															-26.58	-57.96	98.03	57.56	24.58

Gossamer Bio (FRA:4GB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Gossamer Bio's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(24.584	-	0)	/	226.219
	=	0.11

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Gossamer Bio's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.255	+	181.073)	/	24.584
	=	7.82

Gossamer Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gossamer Bio (FRA:4GB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (FRA:4GB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

GOSS:USA 4GB:Germany

Address

3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121

Website

https://www.gossamerbio.com

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio (FRA:4GB) Headlines

No Headlines